Trial of Suvorexant for Sleep in Children With Autism
Phase 2
26
about 4.6 years
13–17
1 site in CA
What this study is about
Researchers are testing whether suvorexant helps children with autism sleep better. The trial will compare suvorexant to a placebo, using tests like polysomnography and actigraphy to measure sleep patterns. It will last 1664 days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Placebo
- 2.Take Suvorexant
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
suvorexant
oral (Oral Tablet)
Primary: Change from baseline in sleep architecture as measured by polysomnography (PSG) and/or actigraphy, examples include sleep latency and non-rapid eye movement (NREM)
Secondary: Change from baseline in sleep efficiency as measured by actigraphy
Psychiatry / Mental Health